Skip to main content
Monica Shaw, MD, Internal Medicine, Louisville, KY, UofL Health - UofL Hospital

MonicaShawMD

Internal Medicine • Louisville, KY

Chief, Division of General Internal Medicine, Palliative Medicine and Medical Education at University of L

Join to view full profile

Dr. Shaw is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shaw's full profile

Already have an account?

Education & Training

  • University of Louisville School of Medicine
    University of Louisville School of MedicineResidency, Internal Medicine, 1992 - 1995
  • University of Louisville School of Medicine
    University of Louisville School of MedicineClass of 1992

Certifications & Licensure

  • KY State Medical License
    KY State Medical License 1993 - 2025

Publications & Presentations

PubMed

Press Mentions

  • Bristol Myers Squibb’s Abecma (Idecabtagene Vicleucel) Becomes First CAR T Cell Therapy Approved in the European Union in Earlier Lines for Triple-Class Exposed Relapsed and Refractory Multiple Myeloma
    Bristol Myers Squibb’s Abecma (Idecabtagene Vicleucel) Becomes First CAR T Cell Therapy Approved in the European Union in Earlier Lines for Triple-Class Exposed Relapsed and Refractory Multiple MyelomaMarch 21st, 2024
  • European Commission Expands Approval of Bristol Myers Squibb’s Reblozyl® (Luspatercept) to Include First-Line Treatment of Transfusion-Dependent Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (LR-MDS)
    European Commission Expands Approval of Bristol Myers Squibb’s Reblozyl® (Luspatercept) to Include First-Line Treatment of Transfusion-Dependent Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (LR-MDS)April 3rd, 2024

Hospital Affiliations

Dr. Monica Shaw, Dr. Monica Shaw, MD, Dr. M Shaw